Press release
Creative Diagnostics Launches Monkeypox Virus Antibodies and Antigens to Support MPXV Research
Creative Diagnostics, a global leader in offering raw materials, antibodies, and reagents for the bio-technology industry, announced the launch of several Monkeypox Virus Antibodies and Antigens that have been validated to work in various types of immunoassays and can be used as tools for the detection of Monkeypox viruses.Monkeypox virus (MPV or MPXV) is a double-stranded DNA virus that causes monkeypox in humans and other animals. It belongs to the genus Orthopoxvirus in the family Poxviridae, which is one of the human Orthopoxviruses that include variola (VARV), cowpox (CPX), and vaccinia (VACV) viruses. It is not a direct ancestor to, nor a direct descendant of, the variola virus, which causes smallpox. Rather, monkeypox disease is similar to smallpox but has a milder rash and lower mortality rate. Variation in virulence of the virus has been observed in isolates from Central Africa, where strains are more virulent than those from Western Africa. The two areas have distinct clades of viruses, termed Congo Basin (Central African) and West African clades.
Monkeypox virus can be spread among animals and humans through direct contact with the body fluids or through bite transfection of infected animals. The present outbreak has a toll of over 220 confirmed cases spreading across 19 countries. The U.K., Spain, and Portugal lead the pack with the highest number of confirmed cases. Creative Diagnostics has now developed several Monkeypox Virus Antibodies and Antigens that have been validated to work in various types of immunoassays and can be used as tools for the detection of Monkeypox viruses.
These new Monkeypox Virus Antibodies and Antigens revealed the best performance for MPXV research, as they're prepared in different hosts and are specific to Monkeypox Virus and other Orthopoxvirus. Most importantly, they can be used to identify Monkeypox Virus via ELISA and to develop diagnostic assays. It is noted that these products are intended for research and laboratory use only and are not for diagnostic or clinical use.
Products such as Mouse Anti-Monkeypox Virus Monoclonal antibody, clone 6D8 (CABT-CS618), Human Anti-Monkeypox Virus Monoclonal antibody, clone 6D8 (CABT-CS621), Recombinant Monkeypox Virus E8L Protein His, and Recombinant Monkeypox Virus E8L Protein His are available at Creative Diagnostics.
In addition, Creative Diagnostics also provides a variety of antigens and antibodies of SARS-CoV-2, including SARS-CoV-2 mutant proteins, biotinylated proteins, SARS-CoV-2 antibody pairs, and neutralizing antibodies. These antigens and antibodies can be used for scientific research and the detection of SARS-CoV-2-specific antibodies.
If you want to know more details about Monkeypox Virus Antibodies and Antigens or have any questions regarding research materials, please visit Creative Diagnostics at https://www.creative-diagnostics.com.
Creative Diagnostics
New York, USA
11967
About Creative Diagnostics
Creative Diagnostics is a leading manufacturer and supplier of antibodies, viral antigens, innovative diagnostic components, and critical assay reagents. It also provides contract biologic R&D and manufacturing services to diagnostic manufacturers along with GMP biologics manufacturing for the biopharmaceutical market. It aims to provide a trusted source for all researchers' assay development and manufacturing needs.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Creative Diagnostics Launches Monkeypox Virus Antibodies and Antigens to Support MPXV Research here
News-ID: 2694575 • Views: …
More Releases from Creative Diagnostics
Creative Diagnostics Launches Comprehensive Host Cell DNA Assay Kits for Bioproc …
Creative Diagnostics, a reagent supplier and developer focused on biologics quality control, is pleased to announce the launch of its comprehensive suite of Host Cell DNA Assay Kits. These innovative kits empower researchers and manufacturers to effectively detect and quantify residual host cell DNA impurities in biological products, ensuring product safety and regulatory compliance throughout the biopharmaceutical manufacturing process.
The detection of residual host cell DNA throughout the biopharmaceutical manufacturing process…
Creative Diagnostics Launches New Anti-Small Molecule Label Antibodies to Facili …
Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, has recently announced a series of new Anti-Small Molecule Label Antibodies to facilitate the development of nucleic acid lateral flow immunoassay (NALFIA). These antibodies can specifically bind to small molecule labels and offer customers multiple choices, including Anti Digoxin monoclonal antibodies, Anti-Fluorescien monoclonal antibodies, and Anti-FAM polyclonal antibodies.
Traditional nucleic acid detection methods require trained operators and sophisticated…
Creative Diagnostics Introduces New ELISA Kits to Accelerate Autoimmunity Resear …
Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, has announced a series of new ELISA Kits to assist researchers in studing the mechanisms of autoimmunity, including those associated with anti-neotrophil, anti-nuclear, rheumatic diseases, endocrine autoantibodies, and the neurological system.
The immune system has very powerful effector mechanisms to destroy a wide range of pathogens. Early in the study of immunity, it was recognized that if these…
Creative Diagnostics Launches New Reagent Solutions for Herpesvirus Research
Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, has announced the launch of new reagent solutions for herpesvirus research, including a range of Human Herpesviruses Antibodies designed to help researchers better understand the structure of Herpesvirus entry and develop new treatments and prevention strategies.
The Herpesviridae are a large family of double-stranded DNA enveloped viruses that cause a variety of diseases. The nine human herpesviruses are…
More Releases for Monkeypox
Monkeypox Market Size, Share, and Growth Opportunities 2029
This Monkeypox Market report has been prepared by considering several fragments of the present and upcoming market scenario. The market insights gained through this market research analysis report facilitates more clear understanding of the market landscape, issues that may interrupt in the future, and ways to position definite brand excellently. It consists of most-detailed market segmentation, thorough analysis of major market players, trends in consumer and supply chain…
Monkeypox Treatment Market Is Estimated To Witness High Growth Owing To Increase …
Market Overview:
Monkeypox is an orthopoxvirus that causes rash and skin lesions in humans. The current outbreak has highlighted the need for effective treatments to address monkeypox symptoms and complications.
Market Dynamics:
The Monkeypox Treatment Market is anticipated to witness significant growth over the forecast period, driven by increased monkeypox cases globally. According to the World Health Organization (WHO), as of October 2022, there have been over 77,000 confirmed monkeypox cases across 110…
Global Monkeypox Testing Market Size
According to a new market research report published by Global Market Estimates, the Global Monkeypox Testing Market is expected to grow at a CAGR of 4.5% from 2023 to 2028.
The demand for effective diagnostics in the monkeypox testing market is driven by increasing outbreaks and public health emergencies. Growing awareness among governments and healthcare organizations regarding monitoring and containment boosts market growth. Advanced test kits enable accurate detection and differentiation,…
Monkeypox Testing Market - Unmasking Monkeypox: Accurate Diagnostic Solutions
Newark, New Castle, USA - new report, titled Monkeypox Testing Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Monkeypox Testing market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Monkeypox Testing market. The report offers an overview of the market, which…
Monkeypox Market Research: Market Segmentation and Competitive Analysis
When any business seek to lead the market or make a mark in the market as a fresh emergent, market research report is always central. A comprehensive Monkeypox Market report encompasses a market data that provides a detailed analysis of the ABC industry and its impact based on applications and different geographical regions. The report gives current as well as upcoming technical and financial details of the industry to 2027.…
Europe to Spend USD 18 Million in Monkeypox Testing by the End of 2023; More tha …
According to Arizton's latest research report, the Europe monkeypox testing market to spend USD 18 million by the end of 2023. Growing development of rapid testing methods, advancements in PCR technology, and increasing collaborations among the vendors are the growing trends in the market.
There are only a few MPX test kits available in the market. However, governments make efforts to control the virus due to its rapid spread across…
